ARCHIVES

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Davis Denies “Cherry-Picking” Data To Support Her Claims.

August 1, 2008

American cancer Society Funds 84 Research Grants. NCI, NIGMS To Support Synchrotron Beamlines.

November 16, 2001

NCI Funding Plan For 1983: 20% Cut From Recommended Levels for All Grants, Change In Program Projects

October 8, 1982

Adamson Objects to IOM “Primrose Path of Centralization” In Report

March 3, 1989

Digital Immunoassay PSA Test May Predict Cancer Recurrence

October 28, 2011

Evaluation Finds OIG Provides PIs With Flexibility

June 14, 1991